Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia-Reference-Cited by-同舟云学术

Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia

Published:2022-03-25 Issue:7 Volume:39 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Isitt J. J.¹^ORCID,Roze S.²,Tilden D.³,Arora N.³,Palmer A. J.⁴^ORCID,Jones T.⁵⁶⁷^ORCID,Rentoul D.⁸,Lynch P.⁸

Affiliation:

1. Vyoo Agency San Diego California USA

2. Vyoo Agency Lyon France

3. THEMA Consulting Sydney Australia

4. Menzies Institute for Medical Research The University of Tasmania Hobart Australia

5. Department of Endocrinology and Diabetes Perth Children’s Hospital Perth Western Australia Australia

6. Division of Pediatrics within the Medical School The University of Western Australia Perth Western Australia Australia

7. Children’s Diabetes Centre Telethon Kids Institute The University of Western Australia Perth Western Australia Australia

8. Dexcom San Diego California USA

Funder

Dexcom

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14831

Reference61 articles.

1. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2019

2. Australian Bureau of Statistics.National Health Survey: First results. Accessed April 2021. Retrieved fromhttps://www.abs.gov.au/statistics/health/health‐conditions‐and‐risks/national‐health‐survey‐first‐results/latest‐release

3. JDRF.Economic Cost of Type 1 Diabetes in Australia. 2021 April. Accessed June 2021. Retrieved fromhttps://jdrf.org.au/100years/the‐cost‐of‐t1d/

4. ColagiuriS BrnabicA GomezM FitzgeraldB BuckleyA ColagiuriR.DiabCo$t Australia Type 1: Assessing the burden of Type 1. Diabetes in Australia. Canberra: Diabetes Australia;2009.

5. Insulin-like growth factor-I prevents caspase-mediated apoptosis in Schwann cells

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Cost-Effectiveness of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Adults With Type 1 Diabetes in Iran;Value in Health Regional Issues;2024-09

2. A call to action in improving access to diabetes care in lower- and middle-income countries;The Lancet Regional Health - Western Pacific;2024-09

3. Long-Term Health Economic Evaluation of Intermittently Scanned Glucose Monitoring Compared with Self-Monitoring Blood Glucose in a Real-World Setting in Finnish Adult Individuals with Type 1 Diabetes;Diabetes Technology & Therapeutics;2024-07-04

4. Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data;PharmacoEconomics;2024-06-21

5. Unveiling the interplay between rational, psychological and functional factors in continuous glucose monitoring early adoption: Novel evidence from the Dexcom ONE case in Italy;BMC Health Services Research;2024-06-18